An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
NCT07224373
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL:
AZD0120 - Regimen 1
BIOLOGICAL:
AZD0120 - Regimen 2
Sponsor
AstraZeneca